Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours

Journal of Clinical Pathology

Volumn 59, Issue 2, 2006, Pages 202-206

  Kornprat, P ^a   Rehak, P ^a   Ruschoff J ^b   Langner, C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b KLINIKUM KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER TISSUE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL; SYSTEMATIC REVIEW; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; RECEPTOR, IGF TYPE 1; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 32544448409     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.028480     Document Type: Article

References (31)

1. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-76.
2. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-64.
3. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003;95:127-37.
4. Pollak MN, Schernhammer ES, Hankinso SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-18.
5. Foulstone E, Prince S, Zaccheo O, et al. Insulin-like growth factor ligands, receptors and binding proteins in cancer. J Pathol 2005;205:145-53.
6. Mauro L, Surmacz E. IGF-I receptor, cell-cell adhesion, tumour development and progression. J Mol Histol 2004;35:247-53.
7. Reinmuth N, Fan F, Liu W, et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, and metastasis of colon cancer. Lab Invest 2002;82:1377-89.
8. Werner H, Karnieli E, Rauscher FJ, et al. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A 1996;93:8318-23.
9. Ouban A, Muraca P, Yeatman T, et al. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol 2003;34:803-8.
10. Freier S, Weiss O, Eran M, et al. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 1999;44:704-8.
11. Peters G, Gongoll S, Langner C, et al. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal cancer. Virchows Arch 2003;443:139-45.
12. Cardillo MR, Monti S, Di Selverio F, et al. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res 2003;23:3825-35.
13. Schips L, Zigeuner R, Ratschek M, et al. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma. Am J Clin Pathol 2004;122:931-7.
14. In: Sobin LH, Wittekind C, eds. TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, Inc, 2002.
15. Albores-Saavedra J, Scoazec JC, Wittekind C, et al. Tumours of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, eds. WHO classification of tumours. Pathology and genetics. Tumours of the digestive system. Lyon: IARC Press, 2000, 203-18).
16. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
17. Nosho K, Yamamoto H, Taniguchi H, et al. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stages of colorectal carcinogenesis. Clin Cancer Res 2004;10:7950-7.
18. North JH Jr, Pack MS, Hong C, et al. Prognostic factors for adenocarcinoma of the gallbladder: an analysis of 162 cases. Am Surg 1998;64:437-40.
19. Ito H, Matros E, Brooks DC, et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 2004;8:183-90.
20. Nakamura M, Miyamoto S, Maeda H, et al. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers. Clin Cancer Res 2004;10:8434-41.
21. Schnarr B, Strunz K, Ohsam J, et al. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer 2000;89:506-13.
22. Peiro G, Lohse P, Mayr D, et al. Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Am J Clin Pathol 2003;120:78-85.
23. Sohda M, Kato H, Miyazaki T, et al. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer. Anticancer Res 2004;24:3029-34.
24. Parker AS, Cheville JC, Lohse C, et al. Expression of insulin-like growth factor 1 receptor and survival in patients with clear cell renal cell carcinoma. J Urol 2003;170:420-4.
25. Lee AV, Hilsenbeck SG, Yee D. IGF system components as prognostic biomarkers in breast cancer. Breast Cancer Res Treat 1998;47:295-302.
26. Peretz S, Kim C, Rockwell S, et al. IGF1 receptor expression protects against microenvironmental stress found in the solid tumor. Radiat Res 2002;158:174-80.
27. Malik IA. Gallbladder cancer: current status. Expert Opin Pharmacother 2004;5:1271-7.
28. Salisbury AJ, Macauly VM. Development of molecular agents for IGF receptor targeting. Horm Metab Res 2003;35:843-9.
29. Baserga R. Targeting the IGF-1 receptor: from rags to riches. Eur J Cancer 2004;40:2013-15.
30. Bahr C, Groner B. The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy. Growth Horm IGF Res 2004;14:287-95.
31. Miyamoto S, Nakamura M, Shitara K, et al. Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers. Clin Cancer Res 2005;11:3494-502.